Information Library
Results for: Faster product development - Product Development & Commercialization
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
Quintiles Acquires VCG & Associates and VCG Bio
Press Release — October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
-
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage
Press Release — September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.
-
A Focus on CNS
Brochure — July 1, 2011
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. -
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Product Solutions
Brochure — May 16, 2011
Product Solutions give pharma the insights needed to better gauge and drive the likelihood of a new product’s success from both clinical and commercial perspectives. -
Quintiles Named a Preferred Provider to Global Health Product Development Partnership Consortium
Press Release — March 25, 2011 – Quintiles has been named a preferred provider to a consortium of 14 global health Product Development Partnerships (PDPs).
-
Biomarkers in Alzheimers Disease
Presentation — March 17, 2011
The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials. -
Asia is Key to Driving Innovation in Drug Development and Overcoming Industry Challenges
Press Release — March 13, 2011 – Asia is rapidly becoming a new frontier for drug development as Western companies seek to develop and register their products, while emerging Asian companies seek new capabilities to globalize products.
